BioVaxys Technology Corp.
BioVaxys Technology Corp.

Indice CSE:
Devise:
BioVaxys Technology Corp. est une société d'immunothérapie au stade clinique développant des plates-formes vaccinales contre le SRAS-CoV-2 et divers cancers.
BioVaxys Technology Corp. (BIOV)
SEDAR Information
Information d'entreprise
Addresse
503, 905 West Pender St.
Vancouver, BC V6C 1L6
CanadaTéléphone
646-452-7000Courriel
[email protected]Date d’inscription à la cote
Mercredi, novembre 21, 2018
Agent de transfert
Odyssey Trust CompanyCapitalisation
Capitalisation:
105,530,845Réservé à l'émission:
34,818,574Company Officers
James Passin, CEO
Kenneth Kovan, COO & President
Craig Loverock, CFO
Communiqués de presse
13/01/2023
BIOVAXYS ANNOUNCES DEBT SETTLEMENT
Bulletins
05/10/2020
2020-1008 – Changement fondamental - Lions Bay Mining Corp./BioVaxys Technology Corp.
le 5 octobre/October 2020
BioVaxys Technology Corp., the issuer resulting from a Fundamental Change of Lions Bay Mining Corp. (LBM), has been approved for listing.
Listing and disclosure documents will be available at www.thecse.com on the trading date.
BioVaxys Technology Corp. is a clinical-stage immunotherapeutics company developing vaccine platforms for SARS-CoV-2 and various cancers.
____________________________
Advertisement
Publicité